US 7220718
Oral treatment of hemophilia
granted A61KA61K38/27A61K38/36
Quick answer
US patent 7220718 (Oral treatment of hemophilia) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/27, A61K38/36, A61K38/4846, A61K48/00